Institut Pasteur Korea is featured in the Pasteur Network 2021-2022 Annual Report.

[Pasteur Network] Newsletter - July~August 2023

Institut Pasteur Korea discusses strategies to expand cooperation with the HKU-Pasteur Research Pole

IPK’s first-in-class TB drug candidate is licensed out by Qurient to TB Alliance for further deve...

[Pasteur Network Job Opening] Regional Strategic Development Officer for the Pasteur Network: Asi...

[New Publication] IPK identified the potent antibacterial efficacy and new mechanism of action of...